CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-15 | Bowden Christopher Chief Medical Officer | Option exercise | +10,000 | $35.16 | $352K | 17,238 |
| 2019-03-15 | Bowden Christopher Chief Medical Officer | Sale | −8,700 | $64.09 | $558K | 8,538 |
| 2019-03-15 | Bowden Christopher Chief Medical Officer | Sale | −1,300 | $64.64 | $84K | 7,238 |
| 2019-03-15 | Bowden Christopher Chief Medical Officer | Option exercise · Stock option (right to buy) | −10,000 | 81,000 | ||
| 2019-03-05 | Biller Scott Chief Scientific Officer | Option exercise | +428 | $31.64 | $14K | 26,939 |
| 2019-03-05 | Biller Scott Chief Scientific Officer | Option exercise | +2,572 | $39.76 | $102K | 29,511 |
| 2019-03-05 | Biller Scott Chief Scientific Officer | Sale | −200 | $66.45 | $13K | 29,311 |
| 2019-03-05 | Biller Scott Chief Scientific Officer | Sale | −2,600 | $67.73 | $176K | 26,711 |
| 2019-03-05 | Biller Scott Chief Scientific Officer | Sale | −200 | $68.22 | $14K | 26,511 |
| 2019-03-05 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | −428 | 11,354 | ||
| 2019-03-05 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | −2,572 | 42,648 | ||
| 2019-03-04 | Hoerter Steven L. Chief Commercial Officer | Option exercise | +5,000 | $39.76 | $199K | 15,941 |
| 2019-03-04 | Hoerter Steven L. Chief Commercial Officer | Sale | −5,000 | $68.00 | $340K | 10,941 |
| 2019-03-04 | Hoerter Steven L. Chief Commercial Officer | Option exercise · Stock option (right to buy) | −5,000 | 50,650 | ||
| 2019-03-01 | Hoerter Steven L. Chief Commercial Officer | Option exercise | +5,000 | $39.76 | $199K | 15,941 |
| 2019-03-01 | Hoerter Steven L. Chief Commercial Officer | Sale | −5,000 | $66.01 | $330K | 10,941 |
| 2019-03-01 | Hoerter Steven L. Chief Commercial Officer | Option exercise · Stock option (right to buy) | −5,000 | 55,650 | ||
| 2019-02-27 | Biller Scott Chief Scientific Officer | Option exercise | +1,766 | $0.47 | $830 | 28,277 |
| 2019-02-27 | Biller Scott Chief Scientific Officer | Option exercise | +4,154 | $9.05 | $38K | 32,431 |
| 2019-02-27 | Biller Scott Chief Scientific Officer | Option exercise | +3,080 | $31.64 | $97K | 35,511 |
Page 53 of 63 · 1,252 trades